| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Research Institute (K.K., T.I., M.T.), Saitama Cancer Center, Ina-machi, Kita-adachi, Saitama 362-0806, Japan; Core Research for Evolutional Science and Technology (CREST) (K.K., T.S., K.-I.M.), Japan Science and Technology Corporation, Kawaguchi 332-0012, Japan; Department of Developmental Biology (T.S., M.K., K.-I.M.), National Institute for Basic Biology, and Department of Molecular Biomechanics (M.K., K.-I.M.), School of Life Science, The Graduate University for Advanced Studies, Okazaki 444-8585, Japan; Department of Biochemistry (M.M.), Saitama Medical School, Moroyama-machi, Iruma-gun, Saitama 350-0451, Japan; and Department of Pediatrics (K.F.), Asahikawa Medical College, Asahikawa 078-8510, Japan
Address all correspondence and requests for reprints to: Professor Ken-ichirou Morohashi, Ph.D., Department of Developmental Biology, National Institute for Basic Biology, Myodaiji-cho, Okazaki 444-8585, Japan. E-mail: moro{at}nibb.ac.jp.
Dosage-sensitive sex reversal-adrenal hypoplasia congenita critical region on the X chromosome, gene 1 (Dax-1, NR0B1) is an orphan nuclear receptor that represses transcription by Ad4 binding protein/steroidogenic factor 1 (Ad4BP/SF-1, NR5A1). Observations on human diseases and the phenotypes of mice, in which the corresponding genes have been disrupted, have elucidated essential roles of these two nuclear receptors in differentiation of steroidogenic tissues. However, little is known about how the functions of these factors are regulated. Here we have examined their subcellular localization and have clarified the molecular mechanisms regulating subcellular localization of Dax-1. Prompted by the finding that nuclear localization of Dax-1 correlates with the presence of Ad4BP/SF-1 in the early stages of pituitary development, we have tested the possibility that interaction between the two factors is essential for the nuclear localization of Dax-1. In vitro studies with cultured cells demonstrated that an interaction involving the LXXLL motifs in the N-terminal repeat region of Dax-1 plays a key role in its subcellular localization. In addition, we found that a mutant form of DAX-1 (L466R), from a patient with adrenal hypoplasia congenita, was defective in nuclear localization in spite of having an intact N terminus. Taken together, the results reveal that the subcellular localization of Dax-1 is influenced by the presence of Ad4BP/SF-1, and that two regions of Dax-1 have important roles for this process.
NURSA Molecule Pages Link:
This article has been cited by other articles:
![]() |
E. P. Sablin, A. Woods, I. N. Krylova, P. Hwang, H. A. Ingraham, and R. J. Fletterick The structure of corepressor Dax-1 bound to its target nuclear receptor LRH-1 PNAS, November 25, 2008; 105(47): 18390 - 18395. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Iyer, Y.-H. Zhang, and E. R. B. McCabe Dosage-Sensitive Sex Reversal Adrenal Hypoplasia Congenita Critical Region on the X Chromosome, Gene 1 (DAX1) (NR0B1) and Small Heterodimer Partner (SHP) (NR0B2) Form Homodimers Individually, as Well as DAX1-SHP Heterodimers Mol. Endocrinol., October 1, 2006; 20(10): 2326 - 2342. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. F. Clem and B. J. Clark Association of the mSin3A-Histone Deacetylase 1/2 Corepressor Complex with the Mouse Steroidogenic Acute Regulatory Protein Gene Mol. Endocrinol., January 1, 2006; 20(1): 100 - 113. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Wu, L. Zhang, and A. M. Bennett The Noncatalytic Amino Terminus of Mitogen-Activated Protein Kinase Phosphatase 1 Directs Nuclear Targeting and Serum Response Element Transcriptional Regulation Mol. Cell. Biol., June 1, 2005; 25(11): 4792 - 4803. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-Y. Park, H.-J. Kim, J.-Y. Kim, M.-Y. Kim, K.-H. Song, K. Cheol Park, K.-Y. Yu, M. Shong, K.-H. Kim, and H.-S. Choi Differential Role of the Loop Region between Helices H6 and H7 within the Orphan Nuclear Receptors Small Heterodimer Partner and DAX-1 Mol. Endocrinol., May 1, 2004; 18(5): 1082 - 1095. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |